152 related articles for article (PubMed ID: 6356153)
1. Stimulation of vessel wall prostacyclin by selective thromboxane synthetase inhibitor OKY 1581.
Mehta J; Mehta P; Ostrowski N
Prostaglandins Leukot Med; 1983 Sep; 12(1):49-52. PubMed ID: 6356153
[TBL] [Abstract][Full Text] [Related]
2. The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease.
Uyama O; Nagatsuka K; Nakabayashi S; Isaka Y; Yoneda S; Kimura K; Abe H
Stroke; 1985; 16(2):241-4. PubMed ID: 3883580
[TBL] [Abstract][Full Text] [Related]
3. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
[TBL] [Abstract][Full Text] [Related]
4. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M
Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196
[TBL] [Abstract][Full Text] [Related]
5. Comparison of umbilical vein models for measurement of relative prostacyclin and thromboxane production.
Mehta P; Mehta J; Crews F; Roy L; Ostrowski N; Horalek C
Prostaglandins; 1982 Dec; 24(6):743-9. PubMed ID: 6820165
[TBL] [Abstract][Full Text] [Related]
6. Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects.
Morio H; Hirai A; Terano T; Tamura Y; Yoshida S
Thromb Haemost; 1993 Mar; 69(3):276-81. PubMed ID: 8470052
[TBL] [Abstract][Full Text] [Related]
7. [Beneficial effect of a selective TXA2 synthetase inhibitor, OKY-046, both on thromboxane B2 production and vascular damage after spinal cord injury in rat spinal cord].
Morimoto K; Ikata T; Tounai T
Nihon Seikeigeka Gakkai Zasshi; 1990 Jan; 64(1):82-8. PubMed ID: 2319197
[TBL] [Abstract][Full Text] [Related]
8. Effect of different amounts of arachidonic acid on vessel wall-generated PGI2 and TXA2.
Mehta J; Mehta P; Ostrowski N
Prostaglandins Leukot Med; 1983 Nov; 12(3):253-9. PubMed ID: 6419235
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary vascular responses to thromboxane A2 as unmasked by OKY-1581. A novel inhibitor of thromboxane synthesis.
Kadowitz PJ; Nandiwada PA; Spannhake EW; Rosenson RS; McNamara DB; Hyman AL
Chest; 1983 May; 83(5 Suppl):72S-74S. PubMed ID: 6404609
[No Abstract] [Full Text] [Related]
10. Effects of a thromboxane synthetase inhibitor and a thromboxane antagonist on release and activity of thromboxane A2 and prostacyclin in vitro.
O'Keefe EH; Liu EC; Greenberg R; Ogletree ML
Prostaglandins; 1985 May; 29(5):785-97. PubMed ID: 3925501
[TBL] [Abstract][Full Text] [Related]
11. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on blood pressure and thromboxane synthesis in spontaneously hypertensive rats.
Gomi T; Ikeda T; Ishimitsu T; Uehara Y
Prostaglandins Leukot Essent Fatty Acids; 1989 Sep; 37(3):139-44. PubMed ID: 2608692
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological studies on the TXA2 synthetase inhibitor (E)-3-[p-(1H-imidazol-1-ylmethyl)phenyl]-2-propenoic acid (OKY-046).
Hiraku S; Taniguchi K; Wakitani K; Omawari N; Kira H; Miyamoto T; Okegawa T; Kawasaki A; Ujiie A
Jpn J Pharmacol; 1986 Jul; 41(3):393-401. PubMed ID: 3093741
[TBL] [Abstract][Full Text] [Related]
13. Effects of selective thromboxane synthetase inhibitor and indomethacin on prostacyclin and thromboxane A2 from ischemic canine heart.
Ogawa K; Sakai K; Ito T; Watanabe J; Satake T
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():371-6. PubMed ID: 6221548
[No Abstract] [Full Text] [Related]
14. Prostacyclin and thromboxane A2 production by human cardiac atrial tissues.
Mehta J; Mehta P
Am Heart J; 1985 Jan; 109(1):1-3. PubMed ID: 3880988
[TBL] [Abstract][Full Text] [Related]
15. Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581.
Casey LC; Fletcher JR; Zmudka MI; Ramwell PW
J Pharmacol Exp Ther; 1982 Aug; 222(2):441-6. PubMed ID: 6896528
[TBL] [Abstract][Full Text] [Related]
16. Effects of a selective thromboxane synthetase inhibitor (OKY-046) in patients with coronary artery disease during exercise.
Shikano M; Ito T; Ogawa K; Satake T
Jpn Heart J; 1987 Sep; 28(5):663-74. PubMed ID: 3323562
[TBL] [Abstract][Full Text] [Related]
17. Effects of nitroglycerin on human vascular prostacyclin and thromboxane A2 generation.
Mehta J; Mehta P; Ostrowski N
J Lab Clin Med; 1983 Jul; 102(1):116-25. PubMed ID: 6406630
[TBL] [Abstract][Full Text] [Related]
18. The role of thromboxane A2 (TxA2) in allergic cutaneous reactions and the effect of (E)-3-[p-(1H-imidazol-1-ylmethyl) phenyl]-2-propenoic acid hydrochloride (OKY-046), a TxA2 synthetase inhibitor.
Nagai H; Yakuo I; Nakatomi I; Inagaki N; Koda A
Prostaglandins Leukot Essent Fatty Acids; 1989 Mar; 35(3):125-30. PubMed ID: 2710796
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of prostaglandin I2 (PG I2) and thromboxane A2 (TXA2) synthetase inhibitor (OKY-1581) on hemodynamics in pregnant dogs.
Murayama K; Kasai H; Adachi T; Utsunomiya O; Ouchi H
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Mar; 35(3):344-50. PubMed ID: 6339650
[TBL] [Abstract][Full Text] [Related]
20. Effects of a selective inhibitor of thromboxane synthetase (OKY-1581) in humans.
Ito T; Ogawa K; Sakai K; Watanabe J; Satake T; Kayama N; Hiraku S; Naito J
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():245-51. PubMed ID: 6221531
[No Abstract] [Full Text] [Related]
[Next] [New Search]